The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Some conceptual models suggest psilocybin may counteract neurodegeneration and Alzheimer's disease. This is attributed to its 5HT2A activation, which is believed to increase neural plasticity, reduce inflammation, and enhance cognitive functions such as creativity, cognitive flexibility, and facial recognition.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
They may also hold promise as anti-inflammatory agents via activation of the serotonin 5HT2A receptor.